Recurrent Urinary Tract InfectionSARUTINCT02705495
Acupuncture for Prevention of Recurrent Urinary Tract Infections.
A study testing acupuncture and Cranberry products in people with Recurrent Urinary Tract Infection, run by Medical University of Graz at 1 site in Austria.
Trial summary
In this multi-centre prospective randomized controlled trial the efficacy of segmental acupuncture in the prevention of recurrent urinary tract infections will be assessed. The study (acupuncture) group will receive 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of… Read more about this study
- Who is it for?
- Ages 18 to 90 years, women only
- Conditions the study is for
- Recurrent Urinary Tract Infection
- What is being tested?
- acupuncture and Cranberry products
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 136 participants
- Where
- 1 siteAustria
- Study dates
- May 2015to Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Recurrent UTIs: Two or more symptomatic UTIs within the last six 6 months or 3 or more infections within the last 12 months.
- At least two positive urine culture within this period of time
- No evidence of current UTI at the time of inclusion
- Women, Age 18 - 90 years
- Informed consent
Who cannot join
- Pregnancy
- Urogenital anatomical abnormality
- Evidence of kidney stones
- Indwelling catheter
- systemic diseases such as renal insufficiency, transplantation, diabetes, or immunodeficiency
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial
In this multi-centre prospective randomized controlled trial the efficacy of segmental acupuncture in the prevention of recurrent urinary tract infections will be assessed. The study (acupuncture) group will receive 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products. The control group will receive recommendation for use of cranberry products only.
Read the detailed description
- Background 1.1. Urinary tract infection Urinary tract infections (UTI) are considered to be the most common bacterial infections, with approximately 80% of all UTIs occurring in women (1). Nearly one in three women is expected to have at least one episode of UTI by the age of 24 years and almost half of all women will experience one UTI during their lifetime (2). Recurrence affect approximately 20-30% of women with initial UTI, although recurrence rates vary widely (3). Recurrent UTIs are a common problem seen in clinical practice with important medical, social and financial implications. Prophylaxis of recurrent UTI is an ongoing challenge with several different management strategies being used (4). Low dose antibiotic prophylaxis for several months is effective, but fosters the development of antibiotic resistance of the causative microorganisms, but also the commensal flora.(4-8). In postmenopausal women vaginal estrogen therapy reduces symptomatic UTI episodes (1, 7). Further prevention strategies include the oral immunostimulant OM-89, the vaginal vaccine Urovac, lactobacilli prophylaxis, cranberry products and acupuncture (5, 7, 9). 1.2.Cranberry products Cranberries have been used in the prevention of UTIs for many years. Cranberries contain two compounds with antiadherence properties that prevent fimbriated Escherichia coli from adhering to uroepithelial cells in the urinary tract (10). A recent review of 24 studies showed that the use of various cranberry products may have a small benefit for women with recurrent UTIs, although differences were not statistically significant (11). 1.3. Acupuncture treatment The effectiveness of acupuncture has been established for a series of different conditions (12, 13). Up to date there are only two clinical trials studying the effect of acupuncture on the prevention of recurrent UTI, both conducted from the same research group. In one controlled trial of 67 adult women acupuncture was significantly more effective in preventing recurrent UTI compared to sham acupuncture than no treatment over an observation period of 6 months (14). In the second trial of 100 women acupuncture, administered twice weekly for 4 weeks, was significantly more effective in reducing the number of UTIs, but also in reducing the volume of residual urine. Acupuncture points were chosen according to patients´ individual diagnoses following traditional Chinese medical patterns. (15)
- Study aims The present study aims to compare acupuncture treatment with standard treatment (recommendation for cranberry intake) in the treatment of uncomplicated recurrent UTIs in women and is designed as a prospective randomized controlled trial. We will assess the number of acute lower UTIs and subsequent treatment, the type and amount of self medication (cranberry products and others), health related quality of life and treatment satisfaction within a defined period of time. The results from this study will help to guide clinical practice with level I evidence and allow for effective treatment with regard to patient needs.
- Methods/ Workplan This patient oriented non-profit clinical study is designed as a randomised controlled trial (6 months) with a follow-up period of 12 months.
Active recruitment: 12 months Randomised controlled trial: 6 months Short-term Follow-up: 12 months 3.1. Active recruitment After Ethics Committee approval patient recruitment will be started. Information material about the study, including contact details, will be provided at the outpatient clinics of the Dep. of Gynecology, the Dep. of Urology, and other local health care providers. During an initial visit patients will be informed about the study and inclusion and exclusion criteria will be evaluated. A structured medical history, including assessment of previous UTIs and other urogenital tract symptoms, will be obtained. After written informed consent is obtained participants will be randomized.
3.2. Randomized Controlled Trial (6 months)
At the time of randomization patients must not have signs or symptoms of an acute UTI, and must not currently receive antibiotic treatment. Randomizing will be done electronically (www.randomizer.at). Patients will be randomized in one of two treatment groups without stratification with a planned ratio of 1:1:
- Acupuncture treatment group 12 acupuncture treatments according to a standardized protocol plus recommendation for use of cranberry products
- Standard treatment group Recommendation for use of cranberry products only
Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, study adherence and completion of study diary. At 6 months a control visit will be scheduled, the RCT will be completed and the main outcome parameter (number of women with no acute UTIs) and secondary outcome parameters (9.2.) will be assessed.
This will be followed by a 12 months short-term Follow-up. 3.3. Short-term Follow-up (12 months) Patients of both treatment groups may use any prophylactic treatment. Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, and use of prophylactic and therapeutic treatments for UTIs.
The study is designed according to the 2010 CONSORT guidelines(16) and the STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines (17).
- Conditions
- Recurrent Urinary Tract Infection
- Being tested
- acupuncture, Cranberry products
- Medical subject headings
- Urinary Tract Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
acupunctureOther
Acupuncture will be performed according to the physiological concept of segmental acupuncture. A fixed schema of acupuncture points will be used irrespective of TCM diagnosis. Needles will be inserted approximately 10 mm under the skin. The "deqi sensation" (a sensation described as numbness, heaviness, and distension) may be obtained, but will not be specifically aimed for. The acupuncture protocol includes body and ear acupuncture.
Cranberry productsDrug
Also called Cranberry tablets and juice
Participants will receive Cranberry products (Urgenin Blasenkapseln® and/or Alpinamed Preiselbeer Granulat ®) - use is recommended but not obligatory.
| Study group | Role | What they receive |
|---|---|---|
| acupuncture | Active comparator | 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products Receives: Other: acupuncture; Drug: Cranberry products |
| Control | Other | Recommendation for use of cranberry products only Receives: Drug: Cranberry products |
What is being measured
The primary outcome is the main question the study is designed to answer.
Urinary tract infection (UTI)
Number of women with no acute UTI at 6 months
Measured: 6 months
Secondary outcomes (3)
Urinary symptoms
Occurrence of urinary symptoms without signs of UTI
Measured: 6 months
Study diary
Use of cranberry products (type, length and amount) assessed by the study diary
Measured: 6 months
Health related quality of life
Health related quality of life as measured by the Kings Health Questionnaire
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2016 (estimated)
- Study startMay 2015
- Primary completionDec 2021
- Study completionJun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Recurrent Urinary Tract InfectionStudies of the same condition, open and under way.
- More trials run by Medical University of GrazThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 136 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Medical University of Graz
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gerda Trutnovsky, Principal investigator, Medical University of Graz
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02705495
- Sponsor's protocol ID
- SARUTI V1.6
- Acronym
- SARUTI
- Status last verified
- Aug 2022
- First submitted
- 1 Feb 2016
- Last updated
- 5 Aug 2022
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT02705495
- Acronym / sponsor ID
- SARUTI / SARUTI V1.6
- Conditions
- Recurrent Urinary Tract Infection
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 136 participants (estimated)
- Lead sponsor
- Medical University of GrazUniversity, hospital or other
- Study start
- May 2015
- Primary completion
- Dec 2021 (actual)
- Study completion
- Jun 2022 (actual)
- First posted
- 10 Mar 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this multi-centre prospective randomized controlled trial the efficacy of segmental acupuncture in the prevention of recurrent urinary tract infections will be assessed. The study (acupuncture) group will receive 12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products. The control group will receive recommendation for use of cranberry products only.
Detailed description
- Background 1.1. Urinary tract infection Urinary tract infections (UTI) are considered to be the most common bacterial infections, with approximately 80% of all UTIs occurring in women (1). Nearly one in three women is expected to have at least one episode of UTI by the age of 24 years and almost half of all women will experience one UTI during their lifetime (2). Recurrence affect approximately 20-30% of women with initial UTI, although recurrence rates vary widely (3). Recurrent UTIs are a common problem seen in clinical practice with important medical, social and financial implications. Prophylaxis of recurrent UTI is an ongoing challenge with several different management strategies being used (4). Low dose antibiotic prophylaxis for several months is effective, but fosters the development of antibiotic resistance of the causative microorganisms, but also the commensal flora.(4-8). In postmenopausal women vaginal estrogen therapy reduces symptomatic UTI episodes (1, 7). Further prevention strategies include the oral immunostimulant OM-89, the vaginal vaccine Urovac, lactobacilli prophylaxis, cranberry products and acupuncture (5, 7, 9). 1.2.Cranberry products Cranberries have been used in the prevention of UTIs for many years. Cranberries contain two compounds with antiadherence properties that prevent fimbriated Escherichia coli from adhering to uroepithelial cells in the urinary tract (10). A recent review of 24 studies showed that the use of various cranberry products may have a small benefit for women with recurrent UTIs, although differences were not statistically significant (11). 1.3. Acupuncture treatment The effectiveness of acupuncture has been established for a series of different conditions (12, 13). Up to date there are only two clinical trials studying the effect of acupuncture on the prevention of recurrent UTI, both conducted from the same research group. In one controlled trial of 67 adult women acupuncture was significantly more effective in preventing recurrent UTI compared to sham acupuncture than no treatment over an observation period of 6 months (14). In the second trial of 100 women acupuncture, administered twice weekly for 4 weeks, was significantly more effective in reducing the number of UTIs, but also in reducing the volume of residual urine. Acupuncture points were chosen according to patients´ individual diagnoses following traditional Chinese medical patterns. (15)
- Study aims The present study aims to compare acupuncture treatment with standard treatment (recommendation for cranberry intake) in the treatment of uncomplicated recurrent UTIs in women and is designed as a prospective randomized controlled trial. We will assess the number of acute lower UTIs and subsequent treatment, the type and amount of self medication (cranberry products and others), health related quality of life and treatment satisfaction within a defined period of time. The results from this study will help to guide clinical practice with level I evidence and allow for effective treatment with regard to patient needs.
- Methods/ Workplan This patient oriented non-profit clinical study is designed as a randomised controlled trial (6 months) with a follow-up period of 12 months.
Active recruitment: 12 months Randomised controlled trial: 6 months Short-term Follow-up: 12 months 3.1. Active recruitment After Ethics Committee approval patient recruitment will be started. Information material about the study, including contact details, will be provided at the outpatient clinics of the Dep. of Gynecology, the Dep. of Urology, and other local health care providers. During an initial visit patients will be informed about the study and inclusion and exclusion criteria will be evaluated. A structured medical history, including assessment of previous UTIs and other urogenital tract symptoms, will be obtained. After written informed consent is obtained participants will be randomized.
3.2. Randomized Controlled Trial (6 months)
At the time of randomization patients must not have signs or symptoms of an acute UTI, and must not currently receive antibiotic treatment. Randomizing will be done electronically (www.randomizer.at). Patients will be randomized in one of two treatment groups without stratification with a planned ratio of 1:1:
- Acupuncture treatment group 12 acupuncture treatments according to a standardized protocol plus recommendation for use of cranberry products
- Standard treatment group Recommendation for use of cranberry products only
Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, study adherence and completion of study diary. At 6 months a control visit will be scheduled, the RCT will be completed and the main outcome parameter (number of women with no acute UTIs) and secondary outcome parameters (9.2.) will be assessed.
This will be followed by a 12 months short-term Follow-up. 3.3. Short-term Follow-up (12 months) Patients of both treatment groups may use any prophylactic treatment. Participants will be contacted bimonthly by telephone and asked about occurrence of UTIs, adverse events, and use of prophylactic and therapeutic treatments for UTIs.
The study is designed according to the 2010 CONSORT guidelines(16) and the STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture) guidelines (17).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| acupuncture | Active comparator | Other: acupuncture, Drug: Cranberry products12 acupuncture treatments according to a standardized protocol, plus recommendation for use of cranberry products |
| Control | Other | Drug: Cranberry productsRecommendation for use of cranberry products only |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Recurrent UTIs: Two or more symptomatic UTIs within the last six 6 months or 3 or more infections within the last 12 months.
- At least two positive urine culture within this period of time
- No evidence of current UTI at the time of inclusion
- Women, Age 18 - 90 years
- Informed consent
Key exclusion criteria (5 listed)
- Pregnancy
- Urogenital anatomical abnormality
- Evidence of kidney stones
- Indwelling catheter
- systemic diseases such as renal insufficiency, transplantation, diabetes, or immunodeficiency
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| acupunctureAcupuncture will be performed according to the physiological concept of segmental acupuncture. A fixed schema of acupuncture points will be used irrespective of TCM diagnosis. Needles will be inserted approximately 10 mm under the skin. The "deqi sensation" (a sensation described as numbness, heaviness, and distension) may be obtained, but will not be specifically aimed for. The acupuncture protocol includes body and ear acupuncture. | Other | acupuncture |
| Cranberry productsAlso: Cranberry tablets and juiceParticipants will receive Cranberry products (Urgenin Blasenkapseln® and/or Alpinamed Preiselbeer Granulat ®) - use is recommended but not obligatory. | Drug | Control, acupuncture |
Primary outcome
Urinary tract infection (UTI)
Time frame: 6 months
Number of women with no acute UTI at 6 months
3 secondary outcomes
Urinary symptoms
Time frame: 6 months
Study diary
Time frame: 6 months
Health related quality of life
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Aug 2022.
- Individual participant dataSharing planned: No
Related trials for Recurrent Urinary Tract Infection
Active, not recruitingObservational study
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women With Recurrent Urinary Tract Infections
Urinary Tract Infections, Menopause
Active, not recruiting
Probiotic Supplement for Recurrent UTIs in Healthy Women (L. Plantarum, L. Rhamnosus, B. Lactis)
Recurrent Urinary Tract Infections
RecruitingPhase 3
Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women
Recurrent Urinary Tract Infections in Women
Active, not recruiting
Effect of a Probiotic on the Urinary Tract Microbiota of Participants With Recurrent Urinary Tract Infection.
Recurrent Urinary Tract Infection
RecruitingPhase 4
Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study
Urinary Tract Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gerda Trutnovsky principal investigator
Medical University of Graz
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing acupuncture and Cranberry products in people with Recurrent Urinary Tract Infection, run by Medical University of Graz at 1 site in Austria.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Urinary tract infection (UTI) (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2022.